MaxCyte Inc (NASDAQ: MXCT) is -46.39% lower on its value in year-to-date trading and has touched a low of $2.14 and a high of $5.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MXCT stock was last observed hovering at around $2.20 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $2.23, the stock is -15.01% and -20.17% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.38 million and changing 1.36% at the moment leaves the stock -40.01% off its SMA200. MXCT registered -52.65% loss for a year compared to 6-month loss of -37.71%.
The stock witnessed a -15.85% gain in the last 1 month and extending the period to 3 months gives it a -45.21%, and is -8.23% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.73% over the week and 5.88% over the month.
MaxCyte Inc (MXCT) has around 114 employees, a market worth around $237.09M and $37.68M in sales. Profit margin for the company is -110.92%. Distance from 52-week low is 4.21% and -57.60% from its 52-week high. The company has generated returns on investments over the last 12 months (-19.26%).
The EPS is expected to grow by 8.33% this year
The shares outstanding are 106.31M, and float is at 97.96M with Short Float at 3.61%.
The top institutional shareholder in the company is BLACKROCK INC. with over 8.14 million shares valued at $31.92 million. The investor’s holdings represent 7.7814 of the MXCT Shares outstanding. As of 2024-06-30, the second largest holder is CADIAN CAPITAL MANAGEMENT, LP with 7.62 million shares valued at $29.88 million to account for 7.285 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 5.65 million shares representing 5.3948 and valued at over $22.13 million, while MILLENNIUM MANAGEMENT LLC holds 4.9484 of the shares totaling 5.18 million with a market value of $20.3 million.
MaxCyte Inc (MXCT) Insider Activity
The most recent transaction is an insider sale by Soleymannezhad Ali, the company’s Chief Commercial Officer. SEC filings show that Soleymannezhad Ali sold 1,211 shares of the company’s common stock on Mar 18 ’25 at a price of $3.18 per share for a total of $3850.0. Following the sale, the insider now owns 59439.0 shares.
MaxCyte Inc disclosed in a document filed with the SEC on Mar 18 ’25 that Sandoval David I. (GENERAL COUNSEL) sold a total of 353 shares of the company’s common stock. The trade occurred on Mar 18 ’25 and was made at $3.18 per share for $1122.0. Following the transaction, the insider now directly holds 64219.0 shares of the MXCT stock.
Still, SEC filings show that on Mar 18 ’25, Swirsky Douglas J (CHIEF FINANCIAL OFFICER) disposed off 6,939 shares at an average price of $3.18 for $22061.0. The insider now directly holds 111,811 shares of MaxCyte Inc (MXCT).
